View:
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20594
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
T Cell Sciences, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
872342100
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ].
(A fee is not required only if the filing person: (1) has a previous
statement on file reporting beneficial ownership of more than five
percent of the class of securities described in Item 1: and (2) has
filed no amendment subsequent thereto reporting beneficial ownership of
five percent or less of such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The Capital Group Companies, Inc.
86-0206507
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
(b)
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5 SOLE VOTING POWER
NONE
6 SHARED VOTING POWER
NUMBER OF
SHARES
NONE
BENEFICIALL
Y OWNED BY
7 SOLE DISPOSITIVE POWER
EACH
REPORTING
NONE
PERSON WITH
8 SHARED DISPOSITIVE POWER
NONE
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
NONE Beneficial ownership disclaimed pursuant to Rule 13d-4 (Please
see Item 4)
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.0%
12 TYPE OF REPORTING PERSON*
HC
SEE INSTRUCTION BEFORE FILLING OUT!
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Amendment No. 1
Item 1(a) Name of Issuer:
T Cell Sciences, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
119 Fourth Avenue
Needham, MA 02194-2725
Item 2(a) Name of Person(s) Filing:
The Capital Group Companies, Inc.
Item 2(b) Address of Principal Business Office:
333 South Hope Street
Los Angeles, CA 90071
Item 2(c) Citizenship: N/A
Item 2(d) Title of Class of Securities:
Common Stock
Item 2(e) CUSIP Number:
872342100
Item 3 The person(s) filing is(are):
(g) [X] Parent Holding Company in accordance with Section
240.13d-1(b)(1)(ii)(G).
Item 4 Ownership
Please note that this filing is not meant to reflect any change
in the beneficial ownership of the securities being reported
herein by the investment management affiliates of The Capital
Group Companies, Inc. ("CGC").
This filing reflects the fact that CGC will no longer report the
beneficial ownership of securities held in accounts which are
under the discretionary investment management of its investment
management affiliates. The Securities and Exchange Commission
("SEC") recently provided guidance on when beneficial ownership
under Rule 13d-1 should be attributed among entities under common
control. (See SEC Release 34-39538.) The guidance clarifies
that in circumstances where the organizational structure of a
parent company and related entities is such that they exercise
investment and voting powers independently, attribution among
entities will not be required. Since CGC is a holding company
and is not involved in investment and voting decisions,
securities beneficially owned by clients of its affiliates will
no longer be attributed to CGC.
Item 5 Ownership of 5% or Less of a Class: [X]
Item 6 Ownership of More than 5% on Behalf of Another Person: N/A
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company: N/A
Item 8 Identification and Classification of Members of the Group: N/A
Item 9 Notice of Dissolution of the Group: N/A
Item 10 Certification
By signing below, I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose
of and do not have the effect of changing or influencing the
control of the issuer of such securities and were not acquired in
connection with or as a participant in any transaction having
such purpose or effect.
Signature
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
Date: July 9, 1998 (For the period ended
December 31, 1997)
Signature: *Larry P. Clemmensen
Name/Title: Larry P. Clemmensen, President
The Capital Group Companies, Inc.
*By
James P. Ryan
Attorney-in-fact
Signed pursuant to a Power of Attorney dated December 4,
1997 included as an Exhibit to Schedule 13G filed with
the Securities and Exchange Commission by The Capital
Group Companies, Inc. on December 10, 1997 with respect
to Viatel Inc.